INVITRO INTERACTIONS OF AGONISTS AND ANTAGONISTS WITH BETA-ADRENERGIC RECEPTORS

被引：26

作者：

ABRAMSON, SN

MOLINOFF, PB

机构：

来源：

BIOCHEMICAL PHARMACOLOGY | 1984年 / 33卷 / 06期

关键词：

D O I：

10.1016/0006-2952(84)90440-4

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：869 / 875

页数：7

共 44 条

[1]

ABRAMSON SN, 1983, PHARMACOLOGIST, V25

[2]

BAROVSKY K, 1980, J CYCLIC NUCL PROT, V6, P297

[3]

BIRD SJ, 1978, J BIOL CHEM, V253, P8826

[4] 2-STEP MODEL OF LIGAND-RECEPTOR INTERACTION [J].

BOEYNAEMS, JM ;

DUMONT, JE .

MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1977, 7 (01) :33-47

[5] BETA-ADRENERGIC-RECEPTOR OF TURKEY ERYTHROCYTE-MEMBRANES - CONFORMATIONAL MODIFICATION BY BETA-ADRENERGIC AGONISTS [J].

BOTTARI, S ;

VAUQUELIN, G ;

DURIEU, O ;

KLUTCHKO, C ;

STROSBERG, AD .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1979, 86 (04) :1311-1318

[6]

CONTRERAS ML, 1982, SOC NEUROSCI, V8

[7]

DELEAN A, 1980, J BIOL CHEM, V255, P7108

[8] CHARACTERISTICS OF BETA-ADRENERGIC-AGONIST BINDING TO RAT ADIPOCYTE MEMBRANES - EVIDENCE THAT (+/-)-[H-3]HYDROXYBENZYLISOPROTERENOL INTERACTS SELECTIVELY WITH THE ADIPOCYTE BETA-ADRENERGIC RECEPTORS [J].

GIUDICELLI, Y ;

LACASA, D ;

AGLI, B .

BIOCHIMICA ET BIOPHYSICA ACTA, 1982, 715 (01) :105-115

[9]

HARDEN TK, 1976, MOL PHARMACOL, V12, P1

[10]

HEGSTRAND LR, 1979, J PHARMACOL EXP THER, V210, P215

← 1 2 3 4 5 →